- Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA 1998; 282: 677–86.
- Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998; 352: 1886–91.
- Cruz JR, Heldal E, Arnadottir T, Juarez I, Enarson DA. Tuberculosis case-finding in Nicaragua: evaluation of routine activities in the control programme. Tuber Lung Dis 1994; 75: 417–22.
- Mason JO. Opportunities for the elimination of tuberculosis. Am Rev Respir Dis 1986; 134: 201–3.
- República de Nicaragua. Resumen Censal. VII Censo Nacional de Poblacion y III de Vivienda 1995. INEC, Managua; 1996.
- World Health Organization. Global Tuberculosis Control: WHO Report, 1999. Geneva: World Health Organization, 1999.
- Enarson DA, Rieder HL, Arnadottir T, Trébucq A. Management of tuberculosis. Guide for low income countries, 5th ed. Paris: IUATLD, 2000.
- Heldal E, Cruz JR, Arnadottir T, Tardencilla A, Enarson DA. Successful management of a National Tuberculosis Program under conditions of war. Int J Tuberc Lung Dis 1997; 1: 16–24.
- Heldal E, Arnadottir T, Cruz JR, Tardencilla A, Chacon L. Low failure rate in standardized retreatment of tuberculosis in Nicaragua. Patient category, drug resistance and survival of “chronic” patients. Int J Tuberc Lung Dis 2001; 5(2) 129–36.
- Informe anual 1999 del Programa de Control de Tuberculosis. Managua, Nicaragua: Ministerio de Salud, 2000.
- Chacon L, Laszlo A, Laines M, Rosales E. Estudio nacional de resistencia inicial en Nicaragua 1997. Int J Tuberc Lung Dis 1999; 3 (Suppl. 1): S116.
- World Health Organization. Framework for effective tuberculosis control. Geneva: World Health Organization, 1994: WHO/TB/94.17.
- Frenk J, Sepúlveda J, Gomez-Dantiés O, McGuinnes MJ, Knaul F. The future of world health. The new world order and international health. Br Med J 1997; 314: 1404–7.
- World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva: World Health Organization, 1997: WHO/TB/97.229.
- World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Report No. 2. Prevalence and Trends. WHO/CDS/2000.278. WHO Geneva, 2000.
- Kruuner A, Sillastu M, Danilovitsh M, Levina K, Svenson SB, Källenius G, et al. Int J Tuberc Lung Dis 1998; 2: 130–3.
- Så sprids tbc till Sverige. Aftonbladet, 27 February 2000: 14–5
- World Health Organization. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug resistant tuberculosis (MDR-TB). Scientific Panel of the Working Group on DOTS-Plus for MDR-TB. Ed.: Arnadottir T, Gupta R, Espinal M, Raviglione M. WHO/CDS/TB/ 2000.279. WHO Geneva, 2000.
- Mintzberg H. The rise and fall of strategic planning. Prentice Hall, Hertfordshire, 1994.
- Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1999–2000. Bull World Health Organ 1994; 72: 213–20.
- De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999; 3: 457–65.
- China Tuberculosis Collaboration. Results of directly observed short course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358–62.
- Chowdury AMR. Success with the DOTS strategy. Lancet 1999; 353: 1003–4.
- Khatri GR, Frieden TR. The status and prospects of tuberculosis control in India. Int J Tuberc Lung Dis 2000; 4: 193–200.
- Netto EM, Dye C, Raviglione MC. Global monitoring and surveillance project: Progress in global tuberculosis control 1995–1996 with emphasis on 22 high-incidence countries. Int J Tuberc Lung Dis 1999; 3: 310–20.
- Dye C, Fengzeng Z, Scheele S, Williams B. Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 2000; 29(3): 558–64.
- Watts J. G8 nations to set up infectious-disease fund [News]. Lancet 2000; 355: 2060.
- http//www.stoptb.org.
- Ellner J. Review: The immune response in human tuberculosis—implications for tuberculosis control. J Infect Dis 1997; 176: 1351–9.
- Rieder HL. How to combat tuberculosis in the year 2000? Respiration 1998; 65: 423–31.
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.